Shanghai, China

Yuyi Qian

This inventor holds 1 USPTO granted patent. Top assignee: Fudan University. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuyi Qian: Innovator in Chemoembolization Therapy

Introduction

Yuyi Qian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in the area of tumor treatment. His innovative work focuses on the preparation of multifunctional microspheres for chemoembolization therapy and imaging of tumors.

Latest Patents

Yuyi Qian holds a patent for a groundbreaking invention titled "Multifunctional microsphere preparation for chemoembolization therapy and imaging of tumors, and preparation method therefor." This patent describes a method for creating microspheres that utilize a polyvinyl alcohol derivative as a framework material. The microspheres are polymerized, crosslinked, and cured with an N-acryl amino acid monomer. They are designed to label radionuclide iodine and can absorb chemotherapeutic drugs, enhancing their effectiveness in tumor treatment.

Career Highlights

Yuyi Qian is affiliated with Fudan University, where he conducts research and develops innovative medical solutions. His work has garnered attention for its potential to improve cancer treatment outcomes. He has a strong academic background and is dedicated to advancing medical technology through his inventions.

Collaborations

Yuyi Qian collaborates with fellow researcher Wei Lu, contributing to the development of new methodologies in the field of medical imaging and treatment.

Conclusion

Yuyi Qian's contributions to the field of chemoembolization therapy and tumor imaging highlight his role as an influential inventor. His innovative approaches have the potential to significantly impact cancer treatment and improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…